BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19240231)

  • 1. Rapid access to preventive intervention development program in the Division of Cancer Prevention of the U.S. National Cancer Institute: an overview.
    Kapetanovic IM
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):698-700. PubMed ID: 19240231
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of the National Cancer Institute in drug development.
    Doroshow J
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):257-8. PubMed ID: 16166997
    [No Abstract]   [Full Text] [Related]  

  • 3. The Comparative Oncology Trials Consortium: using spontaneously occurring cancers in dogs to inform the cancer drug development pathway.
    Gordon I; Paoloni M; Mazcko C; Khanna C
    PLoS Med; 2009 Oct; 6(10):e1000161. PubMed ID: 19823573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemopreventive agent development research program in the Division of Cancer Prevention of the US National Cancer Institute: an overview.
    Crowell JA
    Eur J Cancer; 2005 Sep; 41(13):1889-910. PubMed ID: 16005206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Learning from exceptional drug responders.
    Mullard A
    Nat Rev Drug Discov; 2014 Jun; 13(6):401-2. PubMed ID: 24875081
    [No Abstract]   [Full Text] [Related]  

  • 6. Early-phase development of cancer prevention agents: challenges and opportunities.
    Perloff M; Steele VE
    Cancer Prev Res (Phila); 2013 May; 6(5):379-83. PubMed ID: 23466485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Cancer Institute Formulary: A Public-Private Partnership Providing Investigators Access to Investigational Anticancer Agents.
    Cristofaro JV; Ansher SS; Zwiebel JA; Ivy P; Conley B; Abrams JS; Doroshow JH
    Clin Pharmacol Ther; 2017 May; 101(5):616-618. PubMed ID: 27981567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect on drug development of the National Cancer Institute's Cancer Therapy Evaluation Program.
    Zwiebel J
    Clin Adv Hematol Oncol; 2016 Mar; 14(3):157-9. PubMed ID: 27058027
    [No Abstract]   [Full Text] [Related]  

  • 9. IOM report calls for a more streamlined, faster cancer cooperative trials program.
    Kuehn BM
    JAMA; 2010 Jun; 303(21):2126-7. PubMed ID: 20516407
    [No Abstract]   [Full Text] [Related]  

  • 10. Japan works to shorten "drug lag," boost trials of new drugs.
    Sinha G
    J Natl Cancer Inst; 2010 Feb; 102(3):148-51. PubMed ID: 20107160
    [No Abstract]   [Full Text] [Related]  

  • 11. New NCI drug formulary cuts red tape.
    Weintraub A
    Lab Anim (NY); 2017 Jun; 46(7):285. PubMed ID: 28644447
    [No Abstract]   [Full Text] [Related]  

  • 12. Next steps in clinical trial redesign.
    Nicholas J
    J Natl Cancer Inst; 2012 Jan; 104(2):90-2. PubMed ID: 22215851
    [No Abstract]   [Full Text] [Related]  

  • 13. Update on NCI in vitro drug screen utilities.
    Holbeck SL
    Eur J Cancer; 2004 Apr; 40(6):785-93. PubMed ID: 15120034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute.
    DeWys WD; Greenwald P
    Semin Oncol; 1983 Sep; 10(3):360-4. PubMed ID: 6665563
    [No Abstract]   [Full Text] [Related]  

  • 15. Institutional profile: Developing and evaluating new drugs for cancer treatment: perspectives from the US National Cancer Institute.
    Trimble EL; Abrams JS; Ansher SS; Smith MA; Zwiebel JA; Tomaszewski JE
    Future Med Chem; 2010 Apr; 2(4):555-9. PubMed ID: 21426005
    [No Abstract]   [Full Text] [Related]  

  • 16. NCI Launches Drug Formulary.
    Cancer Discov; 2017 Mar; 7(3):240-241. PubMed ID: 28126712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Cancer Institute: Restructuring to Support the Clinical Trials of the Future.
    Good M; Castro K; Denicoff A; Finnigan S; Parreco L; Germain DS
    Semin Oncol Nurs; 2020 Apr; 36(2):151003. PubMed ID: 32265163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncology's first Phase 0 trial.
    Rowan K
    J Natl Cancer Inst; 2009 Jul; 101(14):978-9. PubMed ID: 19584322
    [No Abstract]   [Full Text] [Related]  

  • 19. NCI Cancer Imaging Program update.
    Croft BY
    J Nucl Med; 2008 Jun; 49(6):40N-42N. PubMed ID: 18511822
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer clinical trials--a chronic but curable crisis.
    Young RC
    N Engl J Med; 2010 Jul; 363(4):306-9. PubMed ID: 20554976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.